Education around access to innovative therapies in dermatology. Issues related to the 340(b)program.
2025 · 4th Quarter (Oct 1 - Dec 31)
INCYTE CORPORATION
Filed by W STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- W STRATEGIES, LLC
- Client
- INCYTE CORPORATION
- Filing UUID
- b3370813-edc0-4a90-b65d-dbbc7779d546
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act.
Literal federal measure citations: H.R.946
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.